• Higher serious morbidity, adverse events among Black patients after bariatric surgery

    28 days ago - By Healio

    Although Black patients had better weight loss outcomes after bariatric surgery, they also had a greater risk for serious morbidity and adverse events, according to data presented at Digestive Disease Week.
    “There are racial disparities in bariatric surgery use even though obesity affects Black patients disproportionately,” Dilhana S. Badurdeen, MBBS, MD, ABOM, from John Hopkins Hospital, told Healio Gastroenterology. “Based on our analysis, Black patients have a higher risk for serious morbidity and adverse events regardless of baseline comorbidities, and type of surgery and
    Read more ...

     

  • Increased alcohol-related liver disease diagnoses amid SARS-CoV-2

    Increased alcohol-related liver disease diagnoses amid SARS-CoV-2

    28 days ago - By Healio

    Researchers reported a significant increase in alcohol-related liver disease diagnoses amid the SARS-CoV-2 pandemic, according to a presentation at Digestive Disease Week.
    “There has been a reported changing prevalence of non-COVID-19 diseases during this pandemic,” Travis Roark, MD, Scripps Green Hospital in San Diego, Calif., and colleagues wrote. “There is concern mental health disorders have been exacerbated as people are socially isolated and dealing with profound stressors, leading to behaviors like increased alcohol consumption.”
    Using the Scripps Health
    Read more ...

     

  • Predictors of adverse outcomes among patients with NAFLD, COVID-19

    Predictors of adverse outcomes among patients with NAFLD, COVID-19

    28 days ago - By Healio

    Researchers found certain diagnostics linked to adverse outcomes among patients with non-alcoholic fatty liver disease during COVID-19, according to a presentation at Digestive Disease Week.
    “COVID-19 has consistently shown in multiple studies to disproportionately affect those with metabolic syndrome-associated conditions. Although some smaller studies done during the pandemic reported an increased frequency of severe COVID-19 infection in patients with NAFLD, there is not much that is known in addition to this,” Sunny Sandhu, MD, internal medicine resident at the University of
    Read more ...

     

  • Diabetes drives increase in fatty liver, higher risk for fibrosis in the US

    Diabetes drives increase in fatty liver, higher risk for fibrosis in the US

    28 days ago - By Healio

    Prevalence of fatty liver in the United States increased significantly between 1999 and 2016 with high- and moderate-risk groups also growing, according to a presentation at Digestive Diseases Week.
    “This is an important study to inform policy makers what is it that we are going to deal with in fatty liver disease in the future, so we address treatment strategies and algorithms to identify these patients in the general population and connect and link them to appropriate care,” Zobair Younossi, MD, told Healio. “In 2016, about 38% of patients with fatty liver disease, which is
    Read more ...